Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.270
+0.050 (1.55%)
At close: Sep 18, 2026, 4:00 PM EDT
3.320
+0.050 (1.53%)
After-hours: Sep 18, 2026, 7:57 PM EDT
Evaxion Market Cap
Evaxion has a market cap or net worth of $27.27 million as of September 18, 2026. Its market cap has increased by 47.61% in one year.
Market Cap
27.27M
Enterprise Value
20.38M
1-Year Change
47.61%
Ranking
Category
Stock Price
$3.27
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $27.27M, a decrease of -85.79%. That is a compound annual growth rate of -29.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 27.27M | -31.45% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Quantum BioPharma | 30.09M |
| ABVC BioPharma | 29.81M |
| Kyntra Bio | 29.80M |
| BeyondSpring | 29.15M |
| TransCode Therapeutics | 29.12M |
| IGC Pharma | 27.54M |
| Quince Therapeutics | 27.47M |
| CEL-SCI | 26.21M |